<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormalities in the JAK2/STAT3 pathway are involved in the pathogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), including <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the exact mechanism by which dysregulated JAK2/STAT3 signalling contributes to the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> has not been clarified </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the role of both JAK2 and STAT3 in the mechanism underlying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, we inhibited JAK2 with AG490 and depleted STAT3 with a small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Our data showed that inhibition of JAK2/STAT3 signalling induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cellular <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via modulating the Bcl-2 gene family, promoting the loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> transmembrane potential (Δψm) and the increase of reactive oxygen species </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, our results demonstrated that the translocation of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> (<z:chebi fb="0" ids="16040">Cyt</z:chebi> c), caspase activation and cleavage of poly (<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase (PARP) were present in apoptotic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells after down-regulation of JAK2/STAT3 signalling </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, inhibition of JAK2/STAT3 signalling suppressed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> xenograft <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We found that JAK2/STAT3 target genes were decreased; meanwhile caspase cascade was activated in xenograft <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings illustrated the biological significance of JAK2/STAT3 signalling in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and provided novel evidence that inhibition of JAK2/STAT3 induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> apoptotic pathway </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, JAK2/STAT3 signalling may be a potential target for therapy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>